Platelet Lysate vs Saline for Lumbosacral Radiculopathy

Stopped early · Not applicable

Conditions studied: Lumbosacral Radiculopathy, Lumbar Radiculopathy

In brief

This is a randomized trial to evaluate and compare platelet lysate epidural injection to saline epidural injection for the treatment of lumbar radiculopathy (sciatica).

Key facts

Study ID

NCT06924853

Run by

Regenexx, LLC

People needed

2

Starts

2025-07-01

Expected to finish

2025-11-05

Last updated by the study team

2026-02-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be 18-65 years of age, inclusive, at time of signing informed consent
• At least moderate pain at screening using Patient Global Impression of Severity (PGIS)
• Diagnosis of lumbosacral radiculopathy (LSR) radiating to or below the knee in a single dermatomal pattern (L4, L5, or S1) with onset of clinical symptoms less than 2 year prior to screening visit
• Presence of one of the following: a radicular pattern (L4, L5, or S1) of sensory, reflex or strength changes
• Presence of persistent unilateral radicular pain. Have significant leg pain, numbness, or tingling that causes the patient to alter or change activities.
• LSR pain with inadequate response to conservative care (non-operative); participants must have tried at least one anti-inflammatory or analgesic medication (for at least 2 weeks at adequate doses) and at least one of the following: Physical therapy, bed rest, chiropractic manipulations, home directed lumbar and/or exercise programs.
• Lumbar spine MRI images are available after the onset of clinical symptoms and correlate with localization of clinical symptoms. CT is acceptable for patients with contraindication for MRI.
• Is independent, ambulatory, and can comply with post-treatment evaluations and visits.
• Voluntary signature of the IRB approved Informed Consent

You may not qualify if…

• Untreated underlying psychological conditions (e.g. depression, chronic pain syndrome, etc.) as a contributor of pain
• Bleeding disorders
• Currently taking anticoagulant or immunosuppressive medication
• Evidence on MRI or CT of recent vertebral fracture or segmental instability (spondylolisthesis)
• Inflammatory or auto-immune based pathology (e.g. rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, polymyalgia, polymyositis, gout, pseudogout, etc.)
• Co-existing hip or knee pain localized to the joint structures that may interfere with the participant's ability to participate in the study or interfere with pain assessments
• Any central canal stenosis with neurogenic claudication (not including foraminal stenosis) with pain present mostly during walking and signs of lumbar stenosis on lumbar spine MRI/CT
• Has undergone a surgical procedure for back pain (e.g. discectomy, artificial disc replacement, fusion, etc)
• Presence of spinal cord stimulator
• Received epidural steroid injection or nerve blocks within the last 2 months
• Use of chronic opioids
• Documented history of drug abuse within the last 6 months
• Use of immunosuppressants, oral or intravenous steroids in the last 3 months
• Is pregnant
• Allergy or intolerance to study medication (e.g. lidocaine, etc.)
• Condition represents a worker's comp case and/or is involved in health-related litigation
• Presence of clinically significant disease that may interfere with the evaluation of safety and other clinical outcomes in the study
• Any other condition, that in the opinion of the investigator, would preclude the patient from enrollment.

Where it is running

• Centeno-Schultz Clinic — Broomfield, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.